BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24975391)

  • 1. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
    Danet-Lamasou M; Asselineau J; Perez P; Vivot A; Nunes ML; Loiseau H; San-Galli F; Cherifi-Gatta B; Corcuff JB; Tabarin A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):260-6. PubMed ID: 24975391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
    Carroll TB; Javorsky BR; Findling JW
    Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
    Wang F; Catalino MP; Bi WL; Dunn IF; Smith TR; Guo Y; Hordejuk D; Kaiser UB; Laws ER; Min L
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e94-e102. PubMed ID: 33108450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease.
    Newell-Price J; Pivonello R; Tabarin A; Fleseriu M; Witek P; Gadelha MR; Petersenn S; Tauchmanova L; Ravichandran S; Gupta P; Lacroix A; Biller BMK
    Eur J Endocrinol; 2020 Feb; 182(2):207-217. PubMed ID: 31804965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay for Cushing's disease in an obese population.
    Aberle J; Schulze Zur Wiesch C; Flitsch J; Veigel J; Schön G; Jung R; Reining F; Lautenbach A; Rotermund R; Riedel N
    J Endocrinol Invest; 2018 Nov; 41(11):1325-1331. PubMed ID: 29550934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary Center.
    Guaraldi F; Zoli M; Asioli S; Corona G; Gori D; Friso F; Pasquini E; Bacci A; Sforza A; Mazzatenta D
    J Endocrinol Invest; 2020 Oct; 43(10):1463-1471. PubMed ID: 32215861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cyclic Cushing's disease using late night salivary cortisol testing.
    Jahandideh D; Swearingen B; Nachtigall LB; Klibanski A; Biller BMK; Tritos NA
    Clin Endocrinol (Oxf); 2018 Sep; 89(3):336-345. PubMed ID: 29873834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
    Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
    Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
    De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
    J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.
    Mallari RJ; Thakur JD; Barkhoudarian G; Eisenberg A; Rodriguez A; Rettinger S; Cohan P; Nieman L; Kelly DF
    J Clin Endocrinol Metab; 2022 Jan; 107(1):205-218. PubMed ID: 34478542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
    Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapsing, remitting hypercortisolism in Cushing's disease due to intratumoral hemorrhages in pituitary microadenoma.
    Marko NF; Hamrahian AH; Hatipoglu B; Weil RJ
    J Clin Neurosci; 2013 May; 20(5):753-6. PubMed ID: 23352667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease.
    Carrasco CA; Coste J; Guignat L; Groussin L; Dugué MA; Gaillard S; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4728-34. PubMed ID: 18728161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.
    Findling JW; Fleseriu M; Newell-Price J; Petersenn S; Pivonello R; Kandra A; Pedroncelli AM; Biller BM
    Endocrine; 2016 Nov; 54(2):516-523. PubMed ID: 27209465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of Cushing's disease.
    Dallapiazza RF; Oldfield EH; Jane JA
    Pituitary; 2015 Apr; 18(2):211-6. PubMed ID: 25724315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans.
    Liu H; Bravata DM; Cabaccan J; Raff H; Ryzen E
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):642-9. PubMed ID: 16343098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
    Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
    Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.